Potassium citrate
Generic name
Potassium citrate
Brand name
ATC Code
A12BA02
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
Citrate is metabolized to the hydrogen carbonate. It is primarily excreted in the urine, with less than 5% in unchanged form.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
General Dose Info
108 mg potassiumcitrate equals 0,33 mmol potassiumcitrate
Dosages
| Kidney and bladder stones |
|---|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
POTASSIUM
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Potassium | ||
|---|---|---|
| A12BA30 | ||
| A12BA01 | ||
References
- Habbig S et al, Nephrocalcinosis and urolithiasis in children, Kidney Int, 2011, Dec;80(12):, 1278-91
- Karsli O et al, Metabolic risk factors and the effect of metaphylaxis in pediatric stone disease with hypocitraturia, Urolithiasis, 2013, Feb;41(1), 9-13
- Tekin A et al, Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis, J Urol, 2002, Dec;168(6), 2572-4
Changes
Therapeutic Drug Monitoring
Overdose
